Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)

Basit Öğe Kaydı
dc.contributor.authorBilici, Ahmet
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorSezer, Ahmet
dc.contributor.authorÖksüzoğlu, Berna
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorKaradurmuş, Nuri
dc.contributor.authorÇubukçu, Erdem
dc.contributor.authorŞendur, Mehmet Ali Nahit
dc.contributor.authorAksoy, Sercan
dc.contributor.authorErdem, Dilek
dc.contributor.authorBaşaran, Gül
dc.contributor.authorÇakar, Burcu
dc.contributor.authorŞeker, Mesut
dc.contributor.authorArslan, Çağatay
dc.contributor.authorSezgin Göksu, Sema
dc.contributor.authorÇiçin, İrfan
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorSelçukbiricik, Fatih
dc.contributor.authorHarputluoğlu, Hakan
dc.contributor.authorHelvacı, Kaan
dc.date.accessioned2022-11-07T09:12:18Z
dc.date.available2022-11-07T09:12:18Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipRoche Holdingen_US
dc.identifier.citationBilici, A., Ölmez, Ö. F., Sezer, A., Öksüzoğlu, B., Kaplan, M. A., Karadurmuş, N. ... Helvacı, K. (2022). Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study). Journal of Clinical Oncology.
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9933
dc.identifier.volume40
dc.identifier.wos000863680302513en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHER2PATH Study
dc.subjectBreast Cancer
dc.subjectAnalysis of Pathologic
dc.titleReal-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu